WO2020002387A1 - Composition comprising thymol and hydrogenated palm oil - Google Patents

Composition comprising thymol and hydrogenated palm oil Download PDF

Info

Publication number
WO2020002387A1
WO2020002387A1 PCT/EP2019/066923 EP2019066923W WO2020002387A1 WO 2020002387 A1 WO2020002387 A1 WO 2020002387A1 EP 2019066923 W EP2019066923 W EP 2019066923W WO 2020002387 A1 WO2020002387 A1 WO 2020002387A1
Authority
WO
WIPO (PCT)
Prior art keywords
thymol
composition
palm oil
hydrogenated palm
particles
Prior art date
Application number
PCT/EP2019/066923
Other languages
French (fr)
Inventor
Elger Funda
Ivan de Jesus GAYTAN PEREZ
Original Assignee
Dsm Ip Assets B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets B.V. filed Critical Dsm Ip Assets B.V.
Publication of WO2020002387A1 publication Critical patent/WO2020002387A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/111Aromatic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/30Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72Encapsulation
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Definitions

  • composition comprising thymol and hydrogenated palm oil
  • the present invention relates to a composition suitable for the oral administration of thymol and its use in the feed industry.
  • thymol has been used in traditional medicine. It has been shown to possess various pharmacological properties including antioxidant, free radical scavenging, anti-inflammatory, analgesic, antispasmodic, antibacterial, antifungal, antiseptic and antitumor activities (Meeran et al. Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development. Front Pharmacol. 2017; 8: 380).
  • thymol has been evidenced in the stomach, intestine, and urine after its oral administration with sesame oil at a dose around 500 mg in rats and 1-3 g in rabbits (Schroder V. et al. The excretion of thymol, carvacrol, eugenol and guiacol and the distribution of these substances in the organism. Arch. Exp. Pathol. Pharmak. 1932; 168 331-353).
  • Thymol is a white crystalline substance with a melting point ranging from 49°C to 51 °C. Therefore, thymol crystals as such could be added to a premix comprising vitamins, minerals and other additives. However, thymol as such has an unpleasant taste and smell which makes it less palatable (Nieddu M. et al. Improvement of thymol properties by complexation with cyclodextrins: In vitro and in vivo studies. Carbohyd. Polym. 2014; 102 393-399).
  • the sought-after formulation must release of thymol once the animal has swallowed the formulation, should be storage stable, should be suitable for providing premixes with high blend uniformity, should be easy to manufacture, must be non-toxic and must fulfill the applicable regulatory requirements.
  • the problems underlying the present invention are solved by encapsulating thymol in a matrix which releases thymol at body temperature.
  • the present invention relates to a composition comprising hydrogenated palm oil and thymol.
  • a composition comprising hydrogenated palm oil and thymol.
  • hydrogenated palm oil starts to become soft, the release of thymol is initiated.
  • thymol is fully released.
  • Softening of the material can be seen in a Differential Scanning Calorimetry (DSC) curve as a“shoulder” of the melting point. Softening point denotes the onset temperature of this shoulder, respectively the lowest temperature at which softening starts.
  • DSC Differential Scanning Calorimetry
  • Hydrogenated palm oil without thymol melts over a relatively broad range, due to the presence of a and b polymorphic forms.
  • hydrogenate palm oil without thymol did not fully melt until a temperature of 53°C had been reached. At body temperature, there was only very little softening of the hydrogenated palm oil.
  • thymol to hydrogenated palm oil lowers the softening point of hydrogenated palm oil.
  • body temperature there is already substantial softening of such mixture.
  • the temperature at which thymol is released from the mixture can be fine-tuned by using an appropriate weight ratio between hydrogenated palm oil and thymol.
  • thymol can be further enhanced by the addition of eugenol: a composition that comprises hydrogenated palm oil and thymol is softer at body temperature when said composition also comprises eugenol.
  • a preferred embodiment of the invention relates to particles which comprise or consist of the composition of the invention.
  • Such particles are preferably obtained by spray chilling encapsulation.
  • Spray chilling encapsulation is an easy and cheap manufacturing method.
  • the particles of the invention are storage stable because thymol is encased in an matrix of hydrogenated palm oil. Despite of said encasement, the particles of the invention release thymol once body temperature has been reached.
  • flock uniformity is improved when particles which comprise or consist of the composition of the invention are fed to birds (e.g. broilers) over a period of preferably at least 20 days, more preferably over a period of at least 35 days, starting with day-old birds.
  • birds e.g. broilers
  • a premix comprising such particles can be fed.
  • feed comprising such particles and/or comprising such premix is fed to birds over a period of at least 20 days, more preferably over a period of at least 35 days, starting with day-old broilers.
  • the present invention also relates to the use of particles according to the invention, to the use of the premix of the invention, and to the use of feed of the invention to increase flock uniformity.
  • the use relates to the uniformity of a flock of broilers.
  • composition of the invention comprises hydrogenated palm oil, thymol and optionally piperine.
  • composition of the invention comprises hydrogenated palm oil and thymol.
  • Hydrogenated palm oil is solid. Hydrogenated palm oil may have one or multiple (e.g. two) peaks in its DSC melting curve.
  • the hydrogenated palm oil of the invention has a maximum in its DSC curve between 40°C and 60°C, preferably between 42°C and 55°C and most preferably between 45°C and 50°C, wherein said maximum indicates an endothermic process (melting, i.e. said maximum may be a negative peak).
  • the lowest melting point of the hydrogenated palm oil of the invention is from 39°C to 45°C and is preferably from 40°C to 44°C.
  • the hydrogenated palm oil of the invention may be partially hydrogenated palm oil, fully hydrogenated palm oil or a mixture thereof. Most preferably, the hydrogenated palm oil of the invention is fully hydrogenated palm oil.
  • Advanced delivery formats have been known for some time. Known is in particular the use of temperature-sensitive polymers for drug delivery.
  • the concept of the present invention is different: instead of using an expensive, non-GRAS temperature-sensitive polymer, a surprisingly simple and thus cost-effective composition is used which releases, depending on the temperature, more or less thymol.
  • the composition of the invention At room temperature (25°C), the composition of the invention is solid and encapsulates thymol very effectively. At body temperature of a broiler (40°C), however, the composition becomes soft and the encapsulation of thymol is no longer as effective as before: the release of thymol is initiated.
  • the present invention also relates to the use of the composition of the invention for controlling the release of thymol by temperature.
  • Body temperature induced release of thymol may then be enhanced by a mechanical effect.
  • soft, deformable compositions are deformed in the crop and/or gizzard of the broiler. Said deformation results in an increased surface-to-volume ratio which is expected to further enhance the release of thymol from the composition of the invention.
  • the composition of the invention comprises hydrogenated palm oil and thymol in a weight ratio from 10:1 to 1 :1 .
  • the release of thymol at body temperature can be fine-tuned by modifying said weight ratio.
  • the weight ratio between hydrogenated palm oil and thymol is from 8:1 to 2:1 , is preferably from 7:1 to 3:1 and is most preferably from 6:1 to 5:1.
  • a preferred embodiment of the invention relates to a composition comprising hydrogenated palm oil, thymol and eugenol, wherein the weight ratio between hydrogenated palm oil and thymol is from 10:1 to 1 :1 , preferably from 8:1 to 2:1 , more preferably from 7:1 to 3:1 and most preferably from 6:1 to 5:1.
  • composition of the invention may have any shape.
  • the composition of the invention is preferably a powder which comprises preferably spherical particles.
  • the size of the particles should be adapted to the intended use. In case of a feed additive for broiler, the particles must be small enough to be captured by a chicken.
  • any known method can be used to shape the composition of the invention.
  • a particularly useful method for encapsulating thymol with hydrogenated palm oil is spray chilling encapsulation.
  • said at least one auxiliary compound is silicic acid, calcium sulfate, stearic acid, monopropylene glycol and/or starch.
  • the composition of the invention comprises eugenol and/or said at least one additive, the composition comprises preferably 5-30 weight-% thymol, more preferably 10-20 weight-% thymol and most preferably 12-18 weight-% thymol, based on the total weight of the composition.
  • the composition of the invention comprises eugenol, thymol, piperine and at least one additive.
  • the composition of the invention consists of eugenol, thymol, piperine and at least one additive.
  • molten hydrogenated palm oil being preferably fully hydrogenated palm oil
  • step ii cooling the mixture provided in step i) by spraying said mixture into a cooling medium, said cooling medium being preferably air.
  • the present invention also relates to a method of encapsulating thymol by spray chilling, wherein the composition of the invention is molten before being sprayed.
  • Spray chilling encapsulation improves storage stability of volatile compounds. This also applies to the particles of the invention which are, in addition to having improved storage stability, capable of releasing of thymol once body temperature has been reached.
  • composition or particles of the invention may be added to a premix comprising vitamins, minerals and/or other additives.
  • the present invention also relates to a premix comprising the composition and/or the particles of the invention. Premixes comprising the particles of the invention hardly de-mix, i.e. they have a good blend uniformity.
  • the premix of the invention is added to food or feed.
  • the present invention also relates to food or feed comprising the premix, the composition and/or the particles of the invention.
  • the feed of the invention comprises 0.5-2 weight-%, more preferably 1 weight-% premix of the invention, based on the total weight of the feed.
  • Other preferred amounts are indicated in below table:
  • the present invention also relates to the use of the particles of the present invention for increasing flock uniformity. It also relates to the use of the premix of the present invention for increasing flock uniformity. And it also relates to the use of the feed of the present invention for increasing flock uniformity.
  • the term“flock” refers preferably to a flock of birds, more preferably to a flock of broilers.
  • Flock Uniformity can be expressed as the coefficient of variation (CV) in body weight. Increased CV values are synonymous with decreased uniformity, i.e. a wider spread in body weights above and below the flock average (of. Hughes et al. Flock Uniformity - Is it important and how is it assessed? Aust. Poult. Sci. Symp. 2017).
  • the average final body weight (FBW) of a bird in a specified pen e.g. pen number 1
  • FBW average final body weight
  • a pen typically comprises at least 10 or at least 15 broilers. Because broilers within one pen share one source of feed, the feed intake of an individual broiler within the pen cannot be determined. What can be determined is the total feed intake of all broilers within the specified pen. Due to this reason, the final body weight (FBW) of each and every individual broiler is not measured during standardized trials. What is measured is the total final body weight of all broilers in the specified pen. When said total final body weight of all broilers is divided by the number of broilers within said pen, the average final body weight (FBW) of a broiler in the specified pen is obtained.
  • FBW final body weight
  • FBWd35/pen refers to the average final body weight (FBW) of a broiler in a specified pen when the respective broilers have been fed for 35 days.
  • said 35 feeding days start with day-old broilers.
  • day-old broilers For further details of the calculation, reference is made to example 3.
  • FIGURE 1 shows the DSC melting curve of the samples of example 1. The following symbols are used
  • composition of samples 1 to 4 is shown in below table:
  • Sample 1 (hydrogenated palm oil only) shows two peaks, corresponding to a and b polymorphic forms. Sample 1 was not completely molten until a temperature of 51.3 °C had been reached.
  • sample 2 (thymol only) revealed a melting point of 48.7°C and thus, confirmed the accuracy of the method used in example 1.
  • the partial replacement of hydrogenated palm oil with thymol had a major effect on the melting point: the melting point of sample 3 was determined as 43.9°C. At 38°C the heat flow difference between sample 1 and sample 3 was -0.12588 W/g. At the body temperature of an average broiler (40°C), said difference was even more pronounced. DSC melting curve of sample 3 indicates that softening of sample 3 starts at an even lower temperature. In the crop of broiler, said softening will trigger a deformation of the product. As a result of the increased surface-to-volume ratio of the deformed product, the release of thymol is expected to be further enhanced.
  • compositions of sample 3 and sample 4 enable a temperature responsive delivery of thymol, which is further enhanced by mechanical effects in the crop and/or gizzard of a chicken.
  • Particles comprising the composition of the invention were produced as follows:
  • Molten hydrogenated palm oil was mixed with thymol, eugenol and selected auxiliary compounds.
  • the liquid mixture was cooled by spraying (spray chilling encapsulation). Organoleptic inspection of the obtained particles confirmed a reduced smell.
  • the thus obtained particles were used to prepare a premix. Feed comprising 1 weight-% of said premix, based on the total weight of the feed, was then fed to broiler.
  • Example 3 clearly shows that flock uniformity is improved (i.e. lower CV value) when raising broilers with the feed of the invention (poultry feed 1 ).
  • Flock uniformity decreases (i.e. higher CV value) if the feed comprises thymol and eugenol as such (i.e. without hydrogenated palm oil; poultry feed 2) or if the feed comprises none of these three compounds (poultry feed 3; negative control).
  • Example 3 was repeated at a different research center under similar conditions with a different kind of broilers:
  • Example 4 confirms the outcome of example 3: flock uniformity is clearly improved (i.e. lower CV value) when raising broilers with the feed of the invention. Flock uniformity decreases (i.e. higher CV value) if the feed comprises thymol and eugenol as such (i.e. without hydrogenated palm oil; poultry feed 2) or if the feed comprises none of these three compounds (poultry feed 3; negative control).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to a composition comprising hydrogenated palm oil and thymol in a weight ratio from 10:1 to 1:1. Particles comprising or consisting of such composition enable a temperature responsive delivery of thymol. Delivery of thymol is initiated at about body temperature of a broiler and increases flock uniformity.

Description

Composition comprising thymol and hydrogenated palm oil
Technical field The present invention relates to a composition suitable for the oral administration of thymol and its use in the feed industry.
Background of the invention
For centuries, thymol has been used in traditional medicine. It has been shown to possess various pharmacological properties including antioxidant, free radical scavenging, anti-inflammatory, analgesic, antispasmodic, antibacterial, antifungal, antiseptic and antitumor activities (Meeran et al. Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development. Front Pharmacol. 2017; 8: 380).
The presence of thymol has been evidenced in the stomach, intestine, and urine after its oral administration with sesame oil at a dose around 500 mg in rats and 1-3 g in rabbits (Schroder V. et al. The excretion of thymol, carvacrol, eugenol and guiacol and the distribution of these substances in the organism. Arch. Exp. Pathol. Pharmak. 1932; 168 331-353).
Thymol is a white crystalline substance with a melting point ranging from 49°C to 51 °C. Therefore, thymol crystals as such could be added to a premix comprising vitamins, minerals and other additives. However, thymol as such has an unpleasant taste and smell which makes it less palatable (Nieddu M. et al. Improvement of thymol properties by complexation with cyclodextrins: In vitro and in vivo studies. Carbohyd. Polym. 2014; 102 393-399).
Robbins encapsulated thymol in gelatine capsules before administering it to dogs (Robbins B. H. Quantitative studies on the absorption and excretion of certain resorcinols and cresols in dogs and man. J. Pharmacol. Exp. Therapeut. 1934; 52 54-60). Whereas such an approach reduces the smell and taste of thymol, it is not possible to add gelatine capsules to feed premixes. Gelatine capsules are by far too expensive for the use in the feed industry. Furthermore, a premix containing two-piece gelatine capsules would easily de-mix, i.e. it would have a very poor blend uniformity.
There is a need for a cost-effective manner to reduce smell and/or taste of thymol by providing a suitable galenic formulation of thymol. The sought-after formulation must release of thymol once the animal has swallowed the formulation, should be storage stable, should be suitable for providing premixes with high blend uniformity, should be easy to manufacture, must be non-toxic and must fulfill the applicable regulatory requirements.
There is also a need for a manner to improve flock uniformity. In commercial practice, flock uniformity is important. Many wholesale purchasers of chicken meat insist on a narrow weight range. Failure to meet these specifications can incur severe economic losses (cf. Madsen, T.G. and Pedersen, J.R. (2010) Broiler Flock Uniformity. Feedstuffs 82: 12-13).
Summary of the invention
The problems underlying the present invention are solved by encapsulating thymol in a matrix which releases thymol at body temperature.
Temperature responsive delivery of thymol is challenging. The matrix of such advanced delivery format must be non-toxic, must fulfill regulatory
requirements, must be cheap, must be available at large quantities and should initiate the release of thymol at about body temperature. The present invention relates to a composition comprising hydrogenated palm oil and thymol. When hydrogenated palm oil starts to become soft, the release of thymol is initiated. At the melting point of the composition, thymol is fully released.
Softening of the material can be seen in a Differential Scanning Calorimetry (DSC) curve as a“shoulder” of the melting point. Softening point denotes the onset temperature of this shoulder, respectively the lowest temperature at which softening starts.
Hydrogenated palm oil without thymol melts over a relatively broad range, due to the presence of a and b polymorphic forms. In the experiments of the inventors, hydrogenate palm oil without thymol did not fully melt until a temperature of 53°C had been reached. At body temperature, there was only very little softening of the hydrogenated palm oil.
Surprisingly, the addition of thymol to hydrogenated palm oil lowers the softening point of hydrogenated palm oil. At body temperature, there is already substantial softening of such mixture. The temperature at which thymol is released from the mixture can be fine-tuned by using an appropriate weight ratio between hydrogenated palm oil and thymol.
If desired, the release of thymol can be further enhanced by the addition of eugenol: a composition that comprises hydrogenated palm oil and thymol is softer at body temperature when said composition also comprises eugenol.
A preferred embodiment of the invention relates to particles which comprise or consist of the composition of the invention. Such particles are preferably obtained by spray chilling encapsulation. Spray chilling encapsulation is an easy and cheap manufacturing method. The particles of the invention are storage stable because thymol is encased in an matrix of hydrogenated palm oil. Despite of said encasement, the particles of the invention release thymol once body temperature has been reached.
Surprisingly, flock uniformity is improved when particles which comprise or consist of the composition of the invention are fed to birds (e.g. broilers) over a period of preferably at least 20 days, more preferably over a period of at least 35 days, starting with day-old birds. Such particles can be fed as such. Alternatively, a premix comprising such particles can be fed. Preferably, feed comprising such particles and/or comprising such premix is fed to birds over a period of at least 20 days, more preferably over a period of at least 35 days, starting with day-old broilers. Therefore, the present invention also relates to the use of particles according to the invention, to the use of the premix of the invention, and to the use of feed of the invention to increase flock uniformity. Preferably, the use relates to the uniformity of a flock of broilers.
Detailed description of the invention The composition of the invention comprises hydrogenated palm oil, thymol and optionally piperine. Preferably, the composition of the invention comprises hydrogenated palm oil and thymol.
At room temperature, hydrogenated palm oil is solid. Hydrogenated palm oil may have one or multiple (e.g. two) peaks in its DSC melting curve.
Preferably, the hydrogenated palm oil of the invention has a maximum in its DSC curve between 40°C and 60°C, preferably between 42°C and 55°C and most preferably between 45°C and 50°C, wherein said maximum indicates an endothermic process (melting, i.e. said maximum may be a negative peak). In one embodiment, the lowest melting point of the hydrogenated palm oil of the invention is from 39°C to 45°C and is preferably from 40°C to 44°C. The hydrogenated palm oil of the invention may be partially hydrogenated palm oil, fully hydrogenated palm oil or a mixture thereof. Most preferably, the hydrogenated palm oil of the invention is fully hydrogenated palm oil.
At body temperature, hydrogenated palm oil is softer when thymol and/or eugenol has been added. Advantage can be taken of this effect such that the release of thymol is triggered and/or enhanced at about body temperature.
Advanced delivery formats have been known for some time. Known is in particular the use of temperature-sensitive polymers for drug delivery.
The concept of the present invention is different: instead of using an expensive, non-GRAS temperature-sensitive polymer, a surprisingly simple and thus cost-effective composition is used which releases, depending on the temperature, more or less thymol.
At room temperature (25°C), the composition of the invention is solid and encapsulates thymol very effectively. At body temperature of a broiler (40°C), however, the composition becomes soft and the encapsulation of thymol is no longer as effective as before: the release of thymol is initiated. Thus, the present invention also relates to the use of the composition of the invention for controlling the release of thymol by temperature.
Body temperature induced release of thymol may then be enhanced by a mechanical effect. Without wishing to be bound by theory, it has been hypothesized that soft, deformable compositions are deformed in the crop and/or gizzard of the broiler. Said deformation results in an increased surface-to-volume ratio which is expected to further enhance the release of thymol from the composition of the invention. The composition of the invention comprises hydrogenated palm oil and thymol in a weight ratio from 10:1 to 1 :1 . The release of thymol at body temperature can be fine-tuned by modifying said weight ratio. In a preferred embodiment of the invention, the weight ratio between hydrogenated palm oil and thymol is from 8:1 to 2:1 , is preferably from 7:1 to 3:1 and is most preferably from 6:1 to 5:1.
The release of thymol at body temperature can be further enhanced by adding eugenol. Thus, a preferred embodiment of the invention relates to a composition comprising hydrogenated palm oil, thymol and eugenol, wherein the weight ratio between hydrogenated palm oil and thymol is from 10:1 to 1 :1 , preferably from 8:1 to 2:1 , more preferably from 7:1 to 3:1 and most preferably from 6:1 to 5:1.
The composition of the invention may have any shape. However, the composition of the invention is preferably a powder which comprises preferably spherical particles. The size of the particles should be adapted to the intended use. In case of a feed additive for broiler, the particles must be small enough to be captured by a chicken.
Any known method can be used to shape the composition of the invention. However, a particularly useful method for encapsulating thymol with hydrogenated palm oil is spray chilling encapsulation. For such method, it may be beneficial to add at least one auxiliary compound. Preferably, said at least one auxiliary compound is silicic acid, calcium sulfate, stearic acid, monopropylene glycol and/or starch. When the composition of the invention comprises eugenol and/or said at least one additive, the composition comprises preferably 5-30 weight-% thymol, more preferably 10-20 weight-% thymol and most preferably 12-18 weight-% thymol, based on the total weight of the composition. In one embodiment, the composition of the invention comprises eugenol, thymol, piperine and at least one additive. In a preferred embodiment, the composition of the invention consists of eugenol, thymol, piperine and at least one additive.
The person skilled in the art is familiar with spray chilling encapsulation. Such method comprises preferably the steps:
i. providing a mixture comprising molten hydrogenated palm oil,
thymol, optionally eugenol and optionally at least on auxiliary compound, said molten hydrogenated palm oil being preferably fully hydrogenated palm oil;
ii. cooling the mixture provided in step i) by spraying said mixture into a cooling medium, said cooling medium being preferably air.
Thus, the present invention also relates to a method of encapsulating thymol by spray chilling, wherein the composition of the invention is molten before being sprayed.
Spray chilling encapsulation improves storage stability of volatile compounds. This also applies to the particles of the invention which are, in addition to having improved storage stability, capable of releasing of thymol once body temperature has been reached.
The composition or particles of the invention may be added to a premix comprising vitamins, minerals and/or other additives. Thus, the present invention also relates to a premix comprising the composition and/or the particles of the invention. Premixes comprising the particles of the invention hardly de-mix, i.e. they have a good blend uniformity.
Typically, the premix of the invention is added to food or feed. Thus, the present invention also relates to food or feed comprising the premix, the composition and/or the particles of the invention. Preferably, the feed of the invention comprises 0.5-2 weight-%, more preferably 1 weight-% premix of the invention, based on the total weight of the feed. Other preferred amounts are indicated in below table:
Figure imgf000009_0001
The present invention also relates to the use of the particles of the present invention for increasing flock uniformity. It also relates to the use of the premix of the present invention for increasing flock uniformity. And it also relates to the use of the feed of the present invention for increasing flock uniformity.
In the context of the present invention, the term“flock” refers preferably to a flock of birds, more preferably to a flock of broilers.
The person skilled in the art is familiar with the concept of flock uniformity. Flock Uniformity (FU) can be expressed as the coefficient of variation (CV) in body weight. Increased CV values are synonymous with decreased uniformity, i.e. a wider spread in body weights above and below the flock average (of. Hughes et al. Flock Uniformity - Is it important and how is it assessed? Aust. Poult. Sci. Symp. 2017). In the context of the present invention, the average final body weight (FBW) of a bird in a specified pen (e.g. pen number 1 ) is used as basis for the calculation.
Typically, a pen comprises at least 10 or at least 15 broilers. Because broilers within one pen share one source of feed, the feed intake of an individual broiler within the pen cannot be determined. What can be determined is the total feed intake of all broilers within the specified pen. Due to this reason, the final body weight (FBW) of each and every individual broiler is not measured during standardized trials. What is measured is the total final body weight of all broilers in the specified pen. When said total final body weight of all broilers is divided by the number of broilers within said pen, the average final body weight (FBW) of a broiler in the specified pen is obtained. The term
“FBWd35/pen” refers to the average final body weight (FBW) of a broiler in a specified pen when the respective broilers have been fed for 35 days.
Preferably, said 35 feeding days start with day-old broilers. For further details of the calculation, reference is made to example 3.
Figures
FIGURE 1 shows the DSC melting curve of the samples of example 1. The following symbols are used
Figure imgf000010_0001
On the x-axis, the temperature is shown in °C. On the y-axis, energy flow is shown (normalized, i.e. Watt/g of the composition). Negative energy flow indicates endothermic processes (e.g. melting). Positive energy flow corresponds to exothermic processes. Examples
Example 1
Four samples were prepared by the following process: 1. Melting of hydrogenated palm oil in a 70°C water bath.
2. Addition of the other optional ingredients, one after the other while stirring at 200 rpm.
3. Speed up of stirring (500 rpm) and mix for 3 min.
4. Cool down slowly at room temperature. Temperature was set to 70°C and controlled during steps 1-3 of the preparation process. All ingredients are commercially available. Thymol (purity: 99%) was purchased at VWR Chemicals, eugenol (purity: 99%) at Merk KGaA. Fully hydrogenated palm oil is commercially available.
The composition of samples 1 to 4 is shown in below table:
Figure imgf000011_0001
Table 1
For each of the samples, a melting curve was measured by Differential Scanning Calorimetry, using a Discovery DSC (TA Instruments, Waters GmbH, Eschborn). The obtained DSC melting curves are shown in Figure 1. Melting points were determined by the extrapolated peak onset temperatures (2nd heating cycle at 5°C per minute from -10 °C to 90 °C). Eugenol, if present, was not included as it remained always in liquid state.
Sample 1 (hydrogenated palm oil only) shows two peaks, corresponding to a and b polymorphic forms. Sample 1 was not completely molten until a temperature of 51.3 °C had been reached.
The analysis of sample 2 (thymol only) revealed a melting point of 48.7°C and thus, confirmed the accuracy of the method used in example 1.
The partial replacement of hydrogenated palm oil with thymol (sample 3) had a major effect on the melting point: the melting point of sample 3 was determined as 43.9°C. At 38°C the heat flow difference between sample 1 and sample 3 was -0.12588 W/g. At the body temperature of an average broiler (40°C), said difference was even more pronounced. DSC melting curve of sample 3 indicates that softening of sample 3 starts at an even lower temperature. In the crop of broiler, said softening will trigger a deformation of the product. As a result of the increased surface-to-volume ratio of the deformed product, the release of thymol is expected to be further enhanced.
Softening and melting point are even lower if the composition comprises eugenol in addition to thymol (sample 4). The compositions of sample 3 and sample 4 enable a temperature responsive delivery of thymol, which is further enhanced by mechanical effects in the crop and/or gizzard of a chicken.
Example 2
Particles comprising the composition of the invention were produced as follows:
Molten hydrogenated palm oil was mixed with thymol, eugenol and selected auxiliary compounds. To obtain particles, the liquid mixture was cooled by spraying (spray chilling encapsulation). Organoleptic inspection of the obtained particles confirmed a reduced smell. The thus obtained particles were used to prepare a premix. Feed comprising 1 weight-% of said premix, based on the total weight of the feed, was then fed to broiler.
Example 3
The effect of the particles comprising the composition of the invention on Flock Uniformity (FU) was tested as follows:
A trial was run in one room with multiple pens. Day-old Cobb500 male broilers were randomly allocated to each pen (25 broilers/pen). Three different poultry feeds were tested. For each kind of poultry feed, 12 pens were allocated. Thus, for each kind of poultry feed, 300 broilers were used (12 pens * 25 broilers/pen = 300 broilers) were used. To test all three different poultry feeds, a total of 900 boilers (3 types of feed * 300 broilers/feed = 900 broilers) was used. For each of the three different poultry feeds, standard deviation (SD) and the coefficient of variation (CV) was calculated and expressed as follows:
CV =SD (FBWd35/pen) /Mean (FBWd35/pen)*100
Increased CV values are synonymous with decreased flock uniformity (FU). For an overview of the experimental setting and the details of the statistical analysis, see Table 2.
Figure imgf000014_0001
Figure imgf000014_0002
Table 2 The result of the test is shown in Table 3.
Figure imgf000015_0001
Table 3
Example 3 clearly shows that flock uniformity is improved (i.e. lower CV value) when raising broilers with the feed of the invention (poultry feed 1 ). Flock uniformity decreases (i.e. higher CV value) if the feed comprises thymol and eugenol as such (i.e. without hydrogenated palm oil; poultry feed 2) or if the feed comprises none of these three compounds (poultry feed 3; negative control).
Example 4
Example 3 was repeated at a different research center under similar conditions with a different kind of broilers:
The trial was run in a room with multiple pens. Day-old Ross308 male broilers were randomly allocated to each pen (16 broilers/pen). Three different poultry feeds were tested. For each kind of poultry feed, 12 pens were used. Thus, Thus, for each kind of poultry feed, 192 broilers were used (12 pens * 16 broilers/pen = 192 broilers) were used. To test all three different poultry feeds, a total of 576 boilers (3 types of feed * 192 broilers/feed = 576 broilers) was used.
The result of the trial of example 4 is shown in Table 4.
Figure imgf000016_0001
Table 4
Example 4 confirms the outcome of example 3: flock uniformity is clearly improved (i.e. lower CV value) when raising broilers with the feed of the invention. Flock uniformity decreases (i.e. higher CV value) if the feed comprises thymol and eugenol as such (i.e. without hydrogenated palm oil; poultry feed 2) or if the feed comprises none of these three compounds (poultry feed 3; negative control).

Claims

Claims
1. Composition comprising hydrogenated palm oil and thymol, wherein the weight ratio between hydrogenated palm oil and thymol is from 10:1 to 1 :1.
2. Composition according to claim 1 , wherein the weight ratio between hydrogenated palm oil and thymol is from 8:1 to 2:1 , is preferably from 7:1 to 3:1 and is most preferably from 6:1 to 5:1 and/or wherein said hydrogenated palm oil is fully hydrogenated palm oil.
3. Composition according to claim 1 or 2, wherein said composition further comprises eugenol.
4. Composition according to any one of claims 1 to 3, wherein said
composition further comprises at least one auxiliary compound, and wherein said at least one auxiliary compound is preferably silicic acid, calcium sulfate, stearic acid, monopropylene glycol and/or starch.
5. Composition according to claim 3 or 4, wherein said composition
comprises 5-30 weight-% thymol, preferably 10-20 weight-% thymol and most preferably 12-18 weight-% thymol, based on the total weight of the composition.
6. Particles comprising or consisting of the composition according to any one of claims 1 to 5.
7. Particles according to claim 6, wherein said particles are obtainable by a method comprising the steps
i. providing a mixture comprising molten hydrogenated palm oil, thymol, optionally eugenol and optionally at least on auxiliary compound;
ii. cooling the mixture provided in step i) by spraying said mixture into a cooling medium.
8. Particles according to claim 6 or 7, wherein said particles enable a temperature responsive delivery of thymol.
9. Premix comprising the composition according to any one of claims 1 to 5 or comprising the particles according to any one of claims 6 to 8.
10. Premix according to claim 9, wherein one kilogram of said premix
comprises 0.1 g to 10 g of the composition according to any one of claims 1 to 5, or wherein one kilogram of said premix comprises 0.1 g to 10 g of the particles according to any one of claims 6 to 8.
1 1. Food or feed, comprising the premix of claim 9 or claim 10.
12. Feed according to claim 1 1 , wherein one ton of said feed comprises 10 g to 100 g of the composition according to any one of claims 1 to 5, or wherein one ton of said feed comprises 10 g to 100 g of the particles according to claim 7 or 8.
13. Method of encapsulating thymol by spray chilling, wherein the
composition according to any one of claims 1 to 5 is molten before being sprayed.
14. Use of particles according to any one of claims 6 to 8, or use of the
premix of claim 9 or claim 10, or use of the feed of claim 1 1 or 12 to increase flock uniformity.
15. Use according to claim 14, wherein the uniformity of a flock of birds is increased, and wherein said flock of birds is preferably a flock of broilers.
16. Use of a composition comprising hydrogenated palm oil and thymol for controlling the release of thymol by temperature.
17. Use according to claim 16, wherein the composition according to any one of claims 1 to 5 is used.
PCT/EP2019/066923 2018-06-26 2019-06-26 Composition comprising thymol and hydrogenated palm oil WO2020002387A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18179886.9 2018-06-26
EP18179886 2018-06-26
EP18200584 2018-10-16
EP18200584.3 2018-10-16

Publications (1)

Publication Number Publication Date
WO2020002387A1 true WO2020002387A1 (en) 2020-01-02

Family

ID=67003526

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2019/066923 WO2020002387A1 (en) 2018-06-26 2019-06-26 Composition comprising thymol and hydrogenated palm oil

Country Status (1)

Country Link
WO (1) WO2020002387A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102987093A (en) * 2012-10-29 2013-03-27 安佑(中国)动物营养研发有限公司 Feeding plant essential oil additive as well as preparation and application of additive
WO2014191153A1 (en) * 2013-05-31 2014-12-04 Dsm Ip Assets B.V. Feed supplement and its use
US8980335B2 (en) * 2007-06-29 2015-03-17 Dsm Ip Assets B.V. Use of organic acids and essential oils in animal feeding
CN105076717A (en) * 2015-07-14 2015-11-25 上海美农生物科技股份有限公司 Formula and processing method of feed additive for improving production performance of animals and guaranteeing health of alimentary canals
EP3300724A1 (en) * 2016-09-30 2018-04-04 Erber Aktiengesellschaft Particle containing at least a volatile substance and process for its preparation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980335B2 (en) * 2007-06-29 2015-03-17 Dsm Ip Assets B.V. Use of organic acids and essential oils in animal feeding
CN102987093A (en) * 2012-10-29 2013-03-27 安佑(中国)动物营养研发有限公司 Feeding plant essential oil additive as well as preparation and application of additive
WO2014191153A1 (en) * 2013-05-31 2014-12-04 Dsm Ip Assets B.V. Feed supplement and its use
CN105076717A (en) * 2015-07-14 2015-11-25 上海美农生物科技股份有限公司 Formula and processing method of feed additive for improving production performance of animals and guaranteeing health of alimentary canals
EP3300724A1 (en) * 2016-09-30 2018-04-04 Erber Aktiengesellschaft Particle containing at least a volatile substance and process for its preparation

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
HE WANGQUAN ET AL: "Effects of organic acids and essential oils blend on growth, gut microbiota, immune response and disease resistance of Pacific white shrimp (Litopenaeus vannamei) againstVibrio parahaemolyticus", FISH AND SHELLFISH IMMUNOLOGY, vol. 70, 4 September 2017 (2017-09-04), pages 164 - 173, XP085236540, ISSN: 1050-4648, DOI: 10.1016/J.FSI.2017.09.007 *
HUGHES ET AL.: "Flock Uniformity - Is it important and how is it assessed?", AUST. POULT. SCI. SYMP., 2017
MADSEN, T.G.PEDERSEN, J.R.: "Broiler Flock Uniformity", FEEDSTUFFS, vol. 82, 2010, pages 12 - 13
MEERAN ET AL.: "Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development", FRONT PHARMACOL., vol. 8, 2017, pages 380
MILTON Y DENDY: "ABSTRACTS 2016 International Poultry Scientific Forum Georgia", 2016 INTERNATIONAL POULTRY SCIENTIFIC FORUM JANUARY 25 - 26 ABSTRACTS 2016 INTERNATIONAL POULTRY SCIENTIFIC FORUM GEORGIA WORLD CONGRESS CENTER, 25 January 2016 (2016-01-25), XP055282757, Retrieved from the Internet <URL:http://www.ippexpo.org/ipsf/docs/2016SPSS_AbstractBook.pdf> [retrieved on 20160622] *
NIEDDU M. ET AL.: "Improvement of thymol properties by complexation with cyclodextrins: In vitro and in vivo studies", CARBOHYD. POLYM., vol. 102, 2014, pages 393 - 399
ROBBINS B. H.: "Quantitative studies on the absorption and excretion of certain resorcinols and cresols in dogs and man", J. PHARMACOL. EXP. THERAPEUT, vol. 52, 1934, pages 54 - 60
SCHRODER V. ET AL.: "The excretion of thymol, carvacrol, eugenol and guiacol and the distribution of these substances in the organism", ARCH. EXP. PATHOL. PHARMAK., vol. 168, 1932, pages 331 - 353

Similar Documents

Publication Publication Date Title
AU2012307656B2 (en) Compositions for oral administration to animals, production methods thereof and uses of same
CN112189763A (en) Preparation process and application of plant essential oil microcapsule
EP3545763B1 (en) Particle containing at least one volatile substance, process for its preparation, a food or feed additive containing the same and use
KR101148501B1 (en) Enrofloxacin microcapsule formulation and preparation method thereof
CN109329610A (en) A kind of feed addictive and preparation method thereof for pig
JP2001513096A (en) Method for producing stable and non-hygroscopic salt of L (-) carnitine
CN111714470B (en) Enteric-coated sodium iron ethylene diamine tetraacetate premix for livestock and preparation method thereof
CN111543548B (en) Compound granular oregano oil premix and preparation method thereof
JPS61151133A (en) Slow-releasing coating composition and medicinal drug coated therewith
WO2020002387A1 (en) Composition comprising thymol and hydrogenated palm oil
CN110124580B (en) Tea tree essential oil enteric coated pellet and preparation method and application thereof
CN108210569A (en) A kind of tea tree oil microcapsule and its granule
JP2024509405A (en) Plant essential oil amino acid composition and method for producing the same
CN105147622A (en) Homogeneous olaquindox granules and preparation method thereof
WO2022241968A1 (en) Plant essential oil for prevention and treatment of coccidiosis and use thereof
CN108670948A (en) A kind of nanoscale micro-capsule unimolecule Betagen Solution and preparation method thereof
US8414947B2 (en) Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter
CN105533190A (en) Coated acidifying agent and preparation method thereof
CN107929327A (en) A kind of manufacture craft for improving ox toad granule stability
CN112586610A (en) Extended release formulation for antibiotic replacement therapy
CN105012241B (en) A kind of high stability clopidol solid dispersions
WO2003007928A1 (en) Ascites preventives for poultry
JP2002534970A (en) How to reduce poultry mortality
CN110012903A (en) Can the new merit chigger disease of prevention and control plants essential oil microcapsule formulation and preparation method thereof
EP1530908A1 (en) Process for the preparation of feed comprising additives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19733035

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19733035

Country of ref document: EP

Kind code of ref document: A1